Bioequivalence Study of Clarithromycin 250mg Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2003-11-01
Target enrollment:
Participant gender:
Summary
The objective of the study was to compare the single-dose oral bioavailability of
Clarithromycin 250 mg tablets of Ranbaxy Laboratories with Biaxin 250 mg tablets of Abbott
Laboratories in healthy, adult, human subjects under fasting conditions